Microbial-associated acylated putrescines as immunomodulatory molecules in inflammatory bowel diseases
Bae, S.; Avila-Pacheco, J.; Clay, S. L.; Bang, S.; Scott, M. C.; Andreeva, N.; Michaud, M.; Fonseca-Pereira, D.; Chun, E.; Cao, Y. G.; Zhang, Y.; Bhosle, A.; Perez, R. M.; Pishchany, G.; Vlamakis, H.; El Tekle, G.; Morgan, X. C.; Chen, S. P.; Glickman, J. N.; Xavier, R. J.; Graham, D. B.; Clish, C. B.; Clardy, J.; Franzosa, E. A.; Huttenhower, C.; Garrett, W. S.
Show abstract
The gut microbiota regulates intestinal immunity through metabolite production, yet most disease-associated metabolites remain functionally uncharacterized. In inflammatory bowel diseases (IBD), where the microbial metabolome is profoundly altered, we identify N-acyl putrescines as microbiome-associated metabolites enriched across two independent cohorts. N-oleoylputrescine (NOP) emerges as the primary immunomodulatory candidate, inducing robust transcriptional responses in dendritic cells and colonic organoids. Enterocloster species harboring nonribosomal peptide synthetase gene clusters synthesize NOP, confirmed by isotope-tracing in vitro and germ-free mouse colonization in vivo. NOP suppresses core IBD inflammatory pathways in mouse dendritic cells and human monocytes, reducing signatures of histologic inflammation and therapy non-response. NOP dampens inflammation in four colitis models, decreases myeloid cell NF-{kappa}B activation, and suppresses type 1 immune responses through a T cell-intrinsic mechanism. That NOP accumulates in IBD despite its anti-inflammatory properties reveals a holobiont defense strategy: the gut microbiota deploys immunomodulatory metabolites as a compensatory response to restore homeostasis.
Matching journals
The top 7 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Biosynthetic Enzyme-guided Disease Correlation Connects Gut Microbial Metabolites Sulfonolipids to Inflammatory Bowel Disease Involving TLR4 Signaling 95%
- Interplay between the human gut microbiome and host metabolism 95%
- Metabolic modeling reveals a multi-level deregulation of host-microbiome metabolic networks in IBD 95%
Similar papers in this journal
Similar papers in this journal
- Fecal microbial load is a major determinant of gut microbiome variation and a confounder for disease associations 94%
- An Anaerobic Pathogen Rewires Host Metabolism to Fuel Oxidative Growth in the Inflamed Gut 94%
- Charting the cellular biogeography in colitis reveals fibroblast trajectories and coordinated spatial remodeling 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.